Evidence map›Paper›PMID 42118735›Full record

ArticlePloS one2026

Awareness of and positive attitudes toward HIV pre-exposure prophylaxis among reproductive-aged women in Ghana: A multilevel analysis of the 2022 Demographic and Health Survey.

Florence Gyembuzie Wongnaah, Gilbert Eshun, Mainprice Akuoko Essuman, Collins Adu, Richard Gyan Aboagye

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Florence Gyembuzie WongnaahAbuakwa North Municipal Health Directorate, Ghana Health Service, Kukurantumi, Eastern Region, Ghana.ORCID https://orcid.org/0009-0002-7861-1365
Gilbert EshunSeventh Day Adventist Hospital, Agona-Asamang, Ghana.
Mainprice Akuoko EssumanSaint Louis University School of Medicine, Saint Louis, Missouri, United States of America.
Collins AduCentre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
Richard Gyan AboagyeSchool of Population Health, University of New South Wales, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV pre-exposure prophylaxis (PrEP) is an effective biomedical intervention for preventing HIV acquisition. Using nationally representative data from Ghana, this study examined the factors associated with awareness of and positive attitudes toward PrEP among women of reproductive age.

methodsThe study utilised nationally representative data from the 2022 Ghana Demographic and Health Survey, with a weighted sample of 13,980 women. The outcome variable was awareness of and positive attitudes toward PrEP, assessed based on whether respondents had heard of PrEP and approved of people taking it to prevent acquiring HIV. Data analysis was conducted using Stata 18, employing a multilevel logistic regression model to examine factors associated with awareness of and positive attitudes toward PrEP. Results were reported as adjusted odds ratios (aOR) with 95% confidence intervals (CI).

resultsOverall, 12.1% (95% CI: 11.1-13.3) of women were aware of PrEP and had positive attitudes toward it. The Ahafo region had the highest proportion of women with awareness of and positive attitudes toward PrEP (21.1% [95% CI: 15.7-27.7]), whereas the Savannah region had the lowest (7.2% [95% CI: 5.3-9.9]). Women with two or more sexual partners had lower odds of being aware of and having positive attitudes toward PrEP (aOR = 0.51, 95% CI: 0.28-0.96) than those with no partner. Women aged 25-29 (aOR = 1.75, 95% CI: 1.28-2.40), 30-34 (aOR = 1.61, 95% CI: 1.14-2.27), 35-39 (aOR = 1.69, 95% CI: 1.22-2.32), and 40-44 (aOR = 1.48, 95% CI: 1.03-2.12) had higher odds of awareness of and positive attitudes toward PrEP than women aged 15-19 years. Also, higher odds of awareness of and positive attitudes toward PrEP were observed among women who had heard about other sexually transmitted infections (STIs) (aOR = 1.79, 95% CI: 1.40-2.28), had secondary (aOR = 1.34, 95% CI: 1.06-1.70) and higher education (aOR = 3.27, 95% CI: 2.35-4.55), and listened to radio (aOR = 1.20, 95% CI: 1.01-1.43), compared with those who have not heard of STIs, those with no education, and those who did not listen to the radio, respectively. Additionally, women from Central (aOR = 3.28, 95% CI: 1.76-6.12), Volta (aOR = 3.28, 95% CI: 1.63-6.62), Western North (aOR = 2.59, 95% CI: 1.26-5.29), Ahafo (aOR = 5.02, 95% CI: 2.54-9.91), Bono (aOR = 2.87, 95% CI: 1.37-6.02), Bono East (aOR = 2.87, 95% CI: 1.56-5.26), Oti (aOR = 5.64, 95% CI: 3.06-10.39), Northern (aOR = 2.47, 95% CI: 1.10-5.51), Upper East (aOR = 4.17, 95% CI: 2.05-8.50), and Upper West (aOR = 3.62, 95% CI: 1.85-7.08) regions had higher odds of awareness of and positive attitudes toward PrEP than those in the Western region.

conclusionAbout 1 in 10 women in Ghana were aware of PrEP and held positive attitudes toward it. The factors associated with awareness of and positive attitudes toward PrEP included women's age, educational level, number of sexual partners, listening to the radio, hearing about other STIs, and geographical regions. Policymakers and healthcare providers should focus on interventions that address regional inequalities and barriers to PrEP awareness and facilitate uptake to strengthen HIV prevention efforts in Ghana.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFemaleGhanaHealth SurveysHumansMiddle AgedMultilevel AnalysisYoung Adult

Identifiers

PMID42118735
PMCPMC13166956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.